Indication
This medicinal product is for diagnostic use only. GHRYVELIN is indicated for the diagnosis of growth hormone deficiency (GHD) in adults.
Loading your page…
Loading your page…
Diagnostic Techniques, Endocrine
Marketing Authorisation Holder: Atnahs Pharma Netherlands B.V.
EMA Authorisation: 11/01/2019
INN: macimorelin
AI Drug & Interaction Analysis
Free account required
Ask Osler about Ghryvelin (previously Macimorelin Aeterna Zentaris): drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.